139 related articles for article (PubMed ID: 9555552)
1. Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression.
Pfister C; Buzelin F; Casse C; Bochereau G; Buzelin JM; Bouchot O
Eur Urol; 1998; 33(3):278-84. PubMed ID: 9555552
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of p53 protein in transitional cell carcinoma of the bladder in correlation to DNA ploidy and pathohistological stage and grade.
al-Abadi H; Nagel R; Neuhaus P
Cancer Detect Prev; 1998; 22(1):43-50. PubMed ID: 9466048
[TBL] [Abstract][Full Text] [Related]
3. Quantitative molecular grading of bladder tumours: a tool for objective assessment of the biological potential of urothelial neoplasias.
Bollmann D; Bollmann M; Bankfalvi A; Heller H; Bollmann R; Pajor G; Hildenbrand R
Oncol Rep; 2009 Jan; 21(1):39-47. PubMed ID: 19082441
[TBL] [Abstract][Full Text] [Related]
4. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and immunomarking of bladder urothelial tumors before and after intravesical bacillus Calmette-Guérin treatment.
Kyroudi-Voulgari A; Kouloukoussa M; Simigiatos C; Karakitsos P; Zervas A; Kittas C; Mitropoulos D
Anal Quant Cytol Histol; 2005 Feb; 27(1):52-60. PubMed ID: 15794452
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Krause FS; Feil G; Bichler KH
Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
[TBL] [Abstract][Full Text] [Related]
7. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.
Lianes P; Charytonowicz E; Cordon-Cardo C; Fradet Y; Grossman HB; Hemstreet GP; Waldman FM; Chew K; Wheeless LL; Faraggi D
Clin Cancer Res; 1998 May; 4(5):1267-71. PubMed ID: 9607586
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
[TBL] [Abstract][Full Text] [Related]
9. [DNA ploidy determination with flow cytometry, Ki-67 index and overexpression of p53 protein in 121 T1 superficial bladder carcinomas. Retrospective studies. Part II: Prognostic value and usefulness in the indication for prophylactic treatment with BCG].
Moyano Calvo JL; De Miguel Rodríguez M; Poyato Galán JM; Ortíz Gamiz A; Molina Carranza A; Zerpa Railey JJ; Toro Cepeda H; Sánchez-Barriga Peña D; Galera Davidson H; Castiñeiras Fernández J
Actas Urol Esp; 2001 Jan; 25(1):32-45. PubMed ID: 11284366
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study of p53 and Ki-67 overexpression in grade 3 superficial bladder tumor in relationship to tumor recurrence and prognosis].
Ikegami S; Yoshimura I; Tsuji A; Seta K; Kimura F; Odajima K; Asano T; Hayakawa M
Nihon Hinyokika Gakkai Zasshi; 2001 Nov; 92(7):656-65. PubMed ID: 11766364
[TBL] [Abstract][Full Text] [Related]
12. P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.
Thomas DJ; Robinson MC; Charlton R; Wilkinson S; Shenton BK; Neal DE
Br J Urol; 1994 May; 73(5):533-7. PubMed ID: 8012776
[TBL] [Abstract][Full Text] [Related]
13. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.
Pfister C; Lacombe L; Vezina MC; Moore L; Larue H; Têtu B; Meyer F; Fradet Y
Hum Pathol; 1999 Nov; 30(11):1350-5. PubMed ID: 10571516
[TBL] [Abstract][Full Text] [Related]
15. Paraganglioma of the urinary bladder: can biologic potential be predicted?
Cheng L; Leibovich BC; Cheville JC; Ramnani DM; Sebo TJ; Neumann RM; Nascimento AG; Zincke H; Bostwick DG
Cancer; 2000 Feb; 88(4):844-52. PubMed ID: 10679654
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
17. Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.
Bol MG; Baak JP; van Diermen B; Buhr-Wildhagen S; Janssen EA; Kjellevold KH; Kruse AJ; Mestad O; Øgreid P
J Clin Pathol; 2003 Jun; 56(6):447-52. PubMed ID: 12783972
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
19. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
20. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
